Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Sedana Medical AB ( (SE:SEDANA) ) just unveiled an update.
Sedana Medical AB reported a strong sales growth of 21% in Q2 2025, driven by increased sales and reduced operating costs, despite facing challenges from unrealized currency effects. The company continues its registration preparation work in the USA, impacting cash flow from investments in intangible assets, while maintaining a focus on improving cash flow from operations outside the US.
More about Sedana Medical AB
Sedana Medical AB is a pioneering medtech and pharmaceutical company that specializes in inhaled sedation to enhance patient care during and after sedation. The company offers solutions through its medical device Sedaconda ACD and the pharmaceutical Sedaconda (isoflurane) for mechanically ventilated patients in intensive care. Established in 2005, Sedana Medical is listed on Nasdaq Stockholm and headquartered in Stockholm, Sweden.
Average Trading Volume: 337,226
Current Market Cap: SEK1.14B
Learn more about SEDANA stock on TipRanks’ Stock Analysis page.